Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas

NMR in Biomedicine

Volumn 22, Issue 4, 2009, Pages 449-455

  Khayal, Inas S ^a,b   McKnight, Tracy R ^a,b   McGue, Colleen ^b   Vandenberg, Scott ^b   Lamborn, Kathleen R ^b   Chang, Susan M ^b   Cha, Soonmee ^b   Nelson, Sarah J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apparent diffusion coefficient; Astrocytoma; Diffusion imaging; Fractional anisotropy; Grade 11 gliomas; Oligoastrocytoma; Oligodendroglioma

Indexed keywords

APPARENT DIFFUSION COEFFICIENT; ASTROCYTOMA; DIFFUSION IMAGING; FRACTIONAL ANISOTROPY; GRADE 11 GLIOMAS; OLIGOASTROCYTOMA; OLIGODENDROGLIOMA;

ANISOTROPY; DIAGNOSIS; GADOLINIUM; MULTICARRIER MODULATION;

SURFACE DIFFUSION;

ADULT; ANISOTROPY; ARTICLE; ASTROCYTOMA; BIOPSY; CANCER GRADING; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS; WHITE MATTER; WHOLE BODY IMAGING; AGED; GLIOMA; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANISOTROPY; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED;

EID: 67649233001     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1357     Document Type: Article

References (32)

1. Lopes MB, Laws ER, Jr. Low-grade central nervous system tumors. Neurosurg. Focus 2002; 12: E1.
2. Olson JD, Riedel E, DeAngelis LM. Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 2000; 54: 1442-1448.
3. Shaw EG, Scheithauer BW, O'Fallon JR, Tazelaar HD, Davis DH. Oligodendrogliomas: the Mayo Clinic experience. J. Neurosurg. 1992; 76: 428-434.
4. Fortin D, Macdonald DR, Stitt L, Cairncross JG. PCV for oligodendroglial tumors: in search of prognostic factors for response and survival. Can. J. Neurol. Sci. 2001; 28: 215-223.
5. Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J. Neurosurg. 1992; 76: 741-745.
6. Kitange GJ, Smith JS, Jenkins RB. Genetic alterations and chemotherapeutic response in human diffuse gliomas. Expert Rev. Anticancer Ther. 2001; 1: 595-605.
7. Mason WP, Krol GS, DeAngelis LM. Low-grade oligodendroglioma responds to chemotherapy. Neurology 1996; 46: 203-207.
8. Sasaki H, Zlatescu MC, Betensky RA, Johnk LB, Cutone AN, Cairncross JG, Louis DN. Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma". J. Neuropathol. Exp. Neurol. 2002; 61: 58-63.
9. van den Bent MJ. New perspectives for the diagnosis and treatment of oligodendroglioma. Expert Rev. Anticancer Ther. 2001; 1: 348-356.
10. Le Bihan DJ. Differentiation of benign versus pathologic compression fractures with diffusion-weighted MR imaging: a closer step toward the "holy grail" of tissue characterization? Radiology 1998; 207: 305-307.
11. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161: 401-407.
12. Chenevert TL, Brunberg JA, Pipe JG. Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology 1990; 177: 401-405.
13. Hansen JR. Pulsed NMR study of water mobility in muscle and brain tissue. Biochim. Biophys. Acta 1971; 230: 482-486.
14. Bulakbasi N, Guvenc I, Onguru O, Erdogan E, Tayfun C, Ucoz T. The added value of the apparent diffusion coefficient calculation to magnetic resonance imaging in the differentiation and grading of malignant brain tumors. J. Comput. Assist. Tomogr. 2004; 28: 735-746.
15. Tozer DJ, Jager HR, Danchaivijitr N, Benton CE, Tofts PS, Rees JH, Waldman AD. Apparent diffusion coefficient histograms may predict low-grade glioma subtype. NMR Biomed. 2006.
16. Fitzek C, Mentzel HJ, Fitzek S, Sauner D, Kaiser WA, Reichenbach JR. Echoplanar diffusion-weighted MRI with intravenous gadolinium-DTPA. Neuroradiology 2003; 45: 592-597.
17. Firat A, Şanli B, Karakaş H, Erdem G. The effect of intravenous gadolinium-DTpa on diffusion-weighted imaging. Neuroradiology 2006; 48: 465-470.
18. Yamada K, Kubota H, Kizu O, Nakamura H, Ito H, Yuen S, Tanaka O, Kubota T, Makino M, Van Cauteren M, Nishimura T. Effect of intraveneous gadolinium-DTPA on diffusion-weighted images evaluation of normal brain and infarcts. Stroke 2002; 33: 1799-1802.
19. Basser PJ. Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J. Magn. Reson. B 1996; 111: 209-219.
20. Hartkens T, Rueckert D, Schnabel JA, Hawkes DJ, Hill DLG. VTK CISG registration toolkit: An open source software package for affine and non-rigid registration of single- and multimodal 3D images. BVM 2002, Leipzig, Springer-Verlag, 2002.
21. Nelson SJ, Nalbandian AB, Proctor E, Vigneron DB. Registration of images from sequential MR studies of the brain. J. Magn. Reson. Imaging 1994; 4: 877-883.
22. Saraswathy S. Semi-automated segmentation of brain tumor lesions in MR images. International Society of Magnetic Resonance Imaging, Seattle, WA, USA, 2006.
23. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 2001; 20: 45-57.
24. Gideon P, Thomsen C, Henriksen O. Increased self-diffusion of brain water in normal aging. J. Magn. Reson. Imaging 1994; 4: 185-188.
25. Berger MS, Deliganis AV, Dobbins J, Keles GE. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 1994; 74: 1784-1791.
26. Yamasaki F, Kurisu K, Satoh K, Arita K, Sugiyama K, Ohtaki M, Takaba J, Tominaga A, Hanaya R, Yoshioka H, Hama S, Ito Y, Kajiwara Y, Yahara K, Saito T, Thohar MA. Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 2005; 235: 985-991.
27. Pirzkall A, Nelson SJ, McKnight TR, Takahashi MM, Li X, Graves EE, Verhey LJ, Wara WW, Larson DA, Sneed PK. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 1254-1264.
28. Lee YY, Van Tassel P. Intracranial oligodendrogliomas: imaging findings in 35 untreated cases. AJR Am. J. Roentgenol. 1989; 152: 361-369.
29. Vonofakos D, Marcu H, Hacker H. Oligodendrogliomas: CT patterns with emphasis on features indicating malignancy. J. Comput. Assist. Tomogr. 1979; 3: 783-788.
30. Burger P, Scheithauer B, Vogel F. 2002; Surgical Pathology of the Nervous System and Its Coverings. Churchill Livingstone: New York, NY.
31. Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, Okuda T, Liang L, Ge Y, Komohara Y, Ushio Y, Takahashi M. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J. Magn. Reson. Imaging 1999; 9: 53-60.
32. Gupta RK, Cloughesy TF, Sinha U, Garakian J, Lazareff J, Rubino G, Rubino L, Becker DP, Vinters HV, Alger JR. Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J. Neurooncol. 2000; 50: 215-226.